BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16023504)

  • 1. Endometrial cancer and hormone-replacement therapy.
    Wiegratz I; Kuhl H
    Lancet; 2005 Jul 16-22; 366(9481):201-2. PubMed ID: 16023504
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometrial cancer and hormone-replacement therapy.
    Bjarnason NH
    Lancet; 2005 Jul 16-22; 366(9481):200-1. PubMed ID: 16023503
    [No Abstract]   [Full Text] [Related]  

  • 3. Endometrial adenocarcinoma after prolonged tibolone therapy.
    Nassar AH; Khalil AM; Seoud MA; Usta IM
    Int J Gynaecol Obstet; 2005 Jul; 90(1):78-9. PubMed ID: 15913616
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormones and endometrial cancer--new data from the Million Women Study.
    Brinton LA; Lacey JV; Trimble EL
    Lancet; 2005 Apr 30-May 6; 365(9470):1517-8. PubMed ID: 15866289
    [No Abstract]   [Full Text] [Related]  

  • 5. Endometrial cancer--surprising reports.
    Speroff L
    Maturitas; 2005 Aug; 51(4):329-33. PubMed ID: 16039404
    [No Abstract]   [Full Text] [Related]  

  • 6. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term postmenopausal hormone therapy and endometrial cancer risk: a study by Doherty et al.
    Odem RR; Moniz MH; Allsworth JE; Bleckman CR; Omicioli VA; Lawrence LT; Thaker PH
    Am J Obstet Gynecol; 2007 Aug; 197(2):213-4; discussion e1-5. PubMed ID: 17689656
    [No Abstract]   [Full Text] [Related]  

  • 8. The Million Women Study--is it believable?
    Farmer R
    Climacteric; 2005 Sep; 8(3):210-3. PubMed ID: 16390752
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormone therapy effect in postmenopausal women with history of endometrial cancer].
    Arteaga-Gómez AC; Castellanos-Barroso G; Colin-Valenzuela A; García-Vargas J; Márquez-Acosta G; Reyes-Muñoz E
    Ginecol Obstet Mex; 2011 Jan; 79(1):11-7. PubMed ID: 21966778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
    Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
    Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
    Lyytinen H; Ylikorkala O
    Duodecim; 2011; 127(3):235-42. PubMed ID: 21438346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and endometrial cancer risk: a meta-analysis.
    Grady D; Gebretsadik T; Kerlikowske K; Ernster V; Petitti D
    Obstet Gynecol; 1995 Feb; 85(2):304-13. PubMed ID: 7824251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical practice. Postmenopausal hormone-replacement therapy.
    Manson JE; Martin KA
    N Engl J Med; 2001 Jul; 345(1):34-40. PubMed ID: 11439947
    [No Abstract]   [Full Text] [Related]  

  • 14. The LIBERATE tibolone trial in breast cancer survivors.
    Speroff L
    Maturitas; 2009 May; 63(1):1-3. PubMed ID: 19327923
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone replacement therapy, breast and endometrial cancer.
    La Vecchia C
    Eur J Cancer Prev; 1996 Oct; 5(5):414-6. PubMed ID: 8972283
    [No Abstract]   [Full Text] [Related]  

  • 16. Endometrial effects of tibolone in elderly, osteoporotic women.
    Ettinger B; Kenemans P; Johnson SR; Mol-Arts M; Van Os S; Seifert W; Verweij PJ; Cummings SR
    Obstet Gynecol; 2008 Sep; 112(3):653-9. PubMed ID: 18757665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex endometrial hyperplasia in the context of tibolone administration.
    Kane SC; Quinn MA
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):338-9. PubMed ID: 19566575
    [No Abstract]   [Full Text] [Related]  

  • 18. Balancing safety and efficacy focus on endometrial protection.
    Boroditsky RS
    J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and gynecological cancer.
    Gadducci A; Fanucchi A; Cosio S; Genazzani AR
    Anticancer Res; 1997; 17(5B):3793-8. PubMed ID: 9427782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.